Healthcare Value Capital as of Dec. 31, 2019
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 14 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| GlaxoSmithKline | 13.8 | $4.7M | 100k | 46.99 | |
| Gilead Sciences (GILD) | 13.4 | $4.5M | 70k | 64.99 | |
| Abbvie (ABBV) | 13.0 | $4.4M | 50k | 88.54 | |
| CVS Caremark Corporation (CVS) | 10.9 | $3.7M | 50k | 74.30 | |
| Tyme Technologies | 9.0 | $3.0M | 2.2M | 1.40 | |
| Clovis Oncology | 7.7 | $2.6M | 250k | 10.43 | |
| Viking Therapeutics (VKTX) | 5.9 | $2.0M | 250k | 8.02 | |
| Cardinal Health (CAH) | 5.2 | $1.8M | 35k | 50.57 | |
| AmerisourceBergen (COR) | 5.0 | $1.7M | 20k | 85.00 | |
| Antares Pharma | 4.2 | $1.4M | 300k | 4.70 | |
| McKesson Corporation (MCK) | 4.1 | $1.4M | 10k | 138.30 | |
| Foamix Pharmaceuticals | 3.9 | $1.3M | 400k | 3.34 | |
| Adamas Pharmaceuticals | 2.2 | $758k | 200k | 3.79 | |
| Greenlane Holdings Cl A Ord | 1.7 | $571k | 175k | 3.26 |
